As of Nov 25
| +0.64 / +1.75%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 62.00, with a high estimate of 63.00 and a low estimate of 45.00. The median estimate represents a +66.94% increase from the last price of 37.14.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.